Medical Horizons and Bowhead Health Partner for AI Clinical Solutions in Europe
Medical Horizons and Bowhead Health Inc. have announced an exclusive partnership to bring AI-powered clinical research solutions to Italy, Turkey, and Cyprus, announced in a press release. This collaboration will see Medical Horizons become the exclusive distributor of Bowhead Health's AI-driven platform, Bowhead Navigator, in these regions.
Bowhead Navigator is designed to assist clinicians in matching patients with suitable clinical trials more efficiently. The platform simplifies the trial search process by guiding clinicians through each step and instantly displaying relevant studies. This technology aims to improve clinical trial recruitment, optimize research workflows, and enhance the capabilities of hospitals and research institutes.
The partnership aligns with Medical Horizons' strategy to deliver impactful AI solutions to European healthcare providers. Bowhead Health's platform integrates secure health data management with AI and clinical research, offering a comprehensive solution for personalized patient recruitment and data management. This initiative is part of Bowhead Health's broader efforts to validate its technology with leading hospitals globally.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
Elsevier Pledges 4,000 AI Tool Licenses for European Researchers
Linearis Joins Two Canadian AI Health Data Projects
OpenEvidence and Johns Hopkins Partner on Medical AI and Education
AI in Clinical Trials Market Forecast to Reach USD 7.32 Billion by 2034
AbbVie Partners With Valkai on AI Tools for Clinical Development
Daily AI Brief: the AI news that matters, in your inbox.